EUDA Health Stock to Reverse Split on Monday, March 23rd (NASDAQ:EUDA)

EUDA Health Holdings Limited (NASDAQ:EUDA)’s stock is scheduled to reverse split on the morning of Monday, March 23rd. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, March 22nd.

EUDA Health Price Performance

Shares of NASDAQ EUDA traded down $0.07 during mid-day trading on Thursday, reaching $0.40. The company’s stock had a trading volume of 472,240 shares, compared to its average volume of 149,615. EUDA Health has a 52 week low of $0.36 and a 52 week high of $4.30. The stock has a fifty day moving average of $1.11 and a two-hundred day moving average of $1.93. The firm has a market capitalization of $15.07 million, a PE ratio of -3.32 and a beta of -0.11.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Greenridge Global reduced their price objective on shares of EUDA Health from $6.00 to $2.75 and set a “buy” rating on the stock in a research report on Monday, March 9th. Weiss Ratings reiterated a “sell (d)” rating on shares of EUDA Health in a report on Friday, January 9th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, EUDA Health presently has a consensus rating of “Hold” and a consensus price target of $2.75.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in EUDA Health stock. Citadel Advisors LLC boosted its holdings in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 44,631 shares of the company’s stock after purchasing an additional 16,321 shares during the quarter. Citadel Advisors LLC owned about 0.12% of EUDA Health worth $78,000 as of its most recent SEC filing. 4.35% of the stock is currently owned by institutional investors and hedge funds.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.